Dissecting Schizotypy and Its Association With Cognition and Polygenic Risk for Schizophrenia in a Nonclinical Sample.

general intellectual functioning negative symptoms polygenic risk positive symptoms schizophrenia schizotypy

Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
07 09 2023
Historique:
medline: 8 9 2023
pubmed: 5 3 2023
entrez: 4 3 2023
Statut: ppublish

Résumé

Schizotypy is a multidimensional construct that captures a continuum of risk for developing schizophrenia-spectrum psychopathology. Existing 3-factor models of schizotypy, consisting of positive, negative, and disorganized dimensions have yielded mixed evidence of genetic continuity with schizophrenia using polygenic risk scores. Here, we propose an approach that involves splitting positive and negative schizotypy into more specific subdimensions that are phenotypically continuous with distinct positive symptoms and negative symptoms recognized in clinical schizophrenia. We used item response theory to derive high-precision estimates of psychometric schizotypy using 251 self-report items obtained from a non-clinical sample of 727 (424 females) adults. These subdimensions were organized hierarchically using structural equation modeling into 3 empirically independent higher-order dimensions enabling associations with polygenic risk for schizophrenia to be examined at different levels of phenotypic generality and specificity. Results revealed that polygenic risk for schizophrenia was associated with variance specific to delusional experiences (γ = 0.093, P = .001) and reduced social interest and engagement (γ = 0.076, P = .020), and these effects were not mediated via the higher-order general, positive, or negative schizotypy factors. We further fractionated general intellectual functioning into fluid and crystallized intelligence in 446 (246 females) participants that underwent onsite cognitive assessment. Polygenic risk scores explained 3.6% of the variance in crystallized intelligence. Our precision phenotyping approach could be used to enhance the etiologic signal in future genetic association studies and improve the detection and prevention of schizophrenia-spectrum psychopathology.

Identifiants

pubmed: 36869759
pii: 7069202
doi: 10.1093/schbul/sbac016
pmc: PMC10483465
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1217-1228

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Références

PLoS One. 2010 Nov 10;5(11):e13929
pubmed: 21085666
Schizophr Bull. 2015 Mar;41 Suppl 2:S408-16
pubmed: 25810055
Arch Gen Psychiatry. 2007 Dec;64(12):1348-55
pubmed: 18056542
Behav Brain Sci. 2006 Apr;29(2):109-25; discussion 125-60
pubmed: 16606477
Nat Neurosci. 2020 Apr;23(4):475-480
pubmed: 32231337
JAMA Psychiatry. 2020 Feb 1;77(2):201-210
pubmed: 31664453
Psychol Med. 2022 Apr;52(6):1069-1079
pubmed: 32758327
Dialogues Clin Neurosci. 2010;12(3):383-92
pubmed: 20954432
Psychol Med. 2009 Dec;39(12):2025-42
pubmed: 19796428
JAMA Psychiatry. 2020 Jul 1;77(7):755-765
pubmed: 32159746
JAMA Psychiatry. 2018 Dec 1;75(12):1271-1279
pubmed: 30208377
Lancet Psychiatry. 2017 Jan;4(1):57-62
pubmed: 27932233
Schizophr Res. 2002 Jul 1;56(1-2):171-85
pubmed: 12084431
Brain. 2019 Feb 1;142(2):471-485
pubmed: 30535067
Annu Rev Clin Psychol. 2019 May 7;15:51-69
pubmed: 30649927
Transl Psychiatry. 2019 Nov 14;9(1):300
pubmed: 31727878
Psychol Med. 2016 Jul;46(10):2025-39
pubmed: 27056796
J Abnorm Psychol. 2016 Nov;125(8):1103-1119
pubmed: 27819471
Acta Psychiatr Scand. 2006 Jul;114(1):55-61
pubmed: 16774662
World Psychiatry. 2021 Feb;20(1):57-63
pubmed: 33432749
Hum Mol Genet. 2018 Aug 1;27(R2):R136-R152
pubmed: 29741616
Schizophr Bull. 2016 May;42(3):832-42
pubmed: 26678674
Schizophr Res. 2003 Jun 1;61(2-3):293-302
pubmed: 12729881
Front Psychiatry. 2014 Feb 21;5:18
pubmed: 24600411
Schizophr Bull. 2015 Mar;41 Suppl 2:S417-26
pubmed: 25810056
Bioinformatics. 2015 May 1;31(9):1466-8
pubmed: 25550326
Schizophr Bull. 2006 Jan;32(1):179-94
pubmed: 16166612
Schizophr Bull. 1980;6(3):477-89
pubmed: 7403809
J Abnorm Psychol. 1978 Aug;87(4):399-407
pubmed: 681612
Psychol Bull. 2009 Jan;135(1):157-71
pubmed: 19210058
J Abnorm Psychol. 1976 Aug;85(4):374-82
pubmed: 956504
World Psychiatry. 2021 Feb;20(1):72-73
pubmed: 33432760
Front Psychiatry. 2015 Oct 23;6:143
pubmed: 26557096
Behav Genet. 2017 Jan;47(1):11-24
pubmed: 27743041
J Educ Psychol. 1966 Oct;57(5):253-70
pubmed: 5918295
J Consult Clin Psychol. 1983 Apr;51(2):215-25
pubmed: 6841765
Assessment. 2011 Sep;18(3):291-307
pubmed: 20644081
Psychiatry Res. 2013 Jun 30;212(3):167-74
pubmed: 23642468
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Schizophr Bull. 2018 Feb 15;44(2):338-347
pubmed: 29036523
Crit Rev Neurobiol. 2000;14(1):1-21
pubmed: 11253953
Am J Psychiatry. 2008 Feb;165(2):203-13
pubmed: 18172019
Schizophr Bull. 2006 Apr;32(2):214-9
pubmed: 16481659
Prog Neurobiol. 2010 Nov;92(3):345-69
pubmed: 20558235
Schizophr Bull. 2019 Sep 11;45(5):1033-1041
pubmed: 30256991
Schizophr Bull. 2018 Oct 15;44(suppl_2):S556-S563
pubmed: 29474661
JAMA Psychiatry. 2021 Oct 1;78(10):1143-1151
pubmed: 34347035
Br J Psychiatry. 2018 Sep;213(3):535-541
pubmed: 30113282
Psychiatry Res. 2012 Apr 30;196(2-3):230-4
pubmed: 22424907
Qual Life Res. 2007;16 Suppl 1:5-18
pubmed: 17375372
Schizophr Bull. 2019 Jun 18;45(4):725-729
pubmed: 30541136
Schizophr Res. 2018 Jul;197:2-8
pubmed: 29129507
Schizophr Bull. 1991;17(4):555-64
pubmed: 1805349
JAMA Psychiatry. 2013 Oct;70(10):1107-12
pubmed: 23925787
Proc Natl Acad Sci U S A. 2011 Sep 13;108 Suppl 3:15639-46
pubmed: 21730136
Acta Psychiatr Scand. 2020 May;141(5):452-464
pubmed: 32091622
Schizophr Bull. 2007 Jul;33(4):912-20
pubmed: 17567627
Am Psychol. 2012 Feb-Mar;67(2):130-59
pubmed: 22233090
Biol Psychiatry. 2019 Jul 1;86(1):16-24
pubmed: 30952359
Hum Mutat. 2012 May;33(5):777-80
pubmed: 22504886
J Abnorm Psychol. 2020 Feb;129(2):143-161
pubmed: 31804095
Schizophr Bull. 2004;30(4):1005-22
pubmed: 15954204
Am J Med Genet B Neuropsychiatr Genet. 2018 Jan;177(1):21-34
pubmed: 28851104
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000372
pubmed: 27148566
Psychiatry Res. 2001 Apr 15;101(3):289-301
pubmed: 11311932
Clin Psychol Rev. 2011 Nov;31(7):1169-82
pubmed: 21855827
Schizophr Res. 2005 Oct 15;78(2-3):293-6
pubmed: 16054803
Am J Med Genet B Neuropsychiatr Genet. 2015 Jul;168B(5):392-401
pubmed: 25963331
Hum Mol Genet. 2017 Oct 1;26(R2):R160-R165
pubmed: 28977440
Annu Rev Clin Psychol. 2009;5:27-48
pubmed: 18976138
JAMA Psychiatry. 2016 Feb;73(2):113-20
pubmed: 26719911
Am J Psychiatry. 2018 Jan 1;175(1):15-27
pubmed: 28969442
Biol Psychiatry. 2020 Jul 1;88(1):18-27
pubmed: 32199605
World Psychiatry. 2020 Jun;19(2):151-172
pubmed: 32394571
Assessment. 2022 Jan;29(1):46-61
pubmed: 34044614
Schizophr Bull. 1999;25(3):553-76
pubmed: 10478789
Transl Psychiatry. 2015 Jun 30;5:e593
pubmed: 26125156
Psychol Med. 2002 Feb;32(2):347-58
pubmed: 11866327
Arch Gen Psychiatry. 2010 Sep;67(9):905-13
pubmed: 20819984
Curr Opin Neurobiol. 2016 Feb;36:23-30
pubmed: 26363129
Lancet. 2009 Aug 22;374(9690):635-45
pubmed: 19700006
Neurosci Biobehav Rev. 2013 Mar;37(3):317-27
pubmed: 23313650
Transl Psychiatry. 2019 Aug 28;9(1):210
pubmed: 31462630
Mol Psychiatry. 2016 Sep;21(9):1188-93
pubmed: 26303664
Annu Rev Clin Psychol. 2014;10:85-110
pubmed: 24313568
Neurosci Biobehav Rev. 2017 Jan;72:50-67
pubmed: 27866942
J Abnorm Psychol. 1985 Aug;94(3):384-96
pubmed: 4031235
Cogn Neuropsychiatry. 2017 May;22(3):186-212
pubmed: 28288547

Auteurs

Jeggan Tiego (J)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.
Monash Biomedical Imaging, Monash University, 770 Blackburn Rd, Clayton, VIC 3800, Australia.

Kate Thompson (K)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.
Monash Biomedical Imaging, Monash University, 770 Blackburn Rd, Clayton, VIC 3800, Australia.

Aurina Arnatkeviciute (A)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.

Ziarih Hawi (Z)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.

Amy Finlay (A)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.

Kristina Sabaroedin (K)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.
Monash Biomedical Imaging, Monash University, 770 Blackburn Rd, Clayton, VIC 3800, Australia.

Beth Johnson (B)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.

Mark A Bellgrove (MA)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.

Alex Fornito (A)

Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC 3800, Australia.
School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia.
Monash Biomedical Imaging, Monash University, 770 Blackburn Rd, Clayton, VIC 3800, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH